Seminars in Oncology
Volume 33, Supplement 5 , Pages 15-22, April 2006

Novel Therapeutic Strategies With Alemtuzumab for Chronic Lymphocytic Leukemia

  • Kanti R. Rai

      Affiliations

    • Dr Rai has received research grant support from Berlex, and honoraria from Berlex and Genentech.
    • Corresponding Author InformationAddress reprint requests to: Kanti Rai, MD, Division of Hematology/Oncology, Long Island Jewish Medical Center, New Hyde Park, NY 11040

Division of Hematology/Oncology, Long Island Jewish Medical Center, New Hyde Park, NY

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(06)00057-1

doi:10.1053/j.seminoncol.2006.01.025

Seminars in Oncology
Volume 33, Supplement 5 , Pages 15-22, April 2006

Article Tools

* Image Usage & Resolution